Genetic and functional analysis of HIV type 1 nef gene derived from long-term nonprogressor children: Association of attenuated variants with slow progression to pediatric AIDS

AIDS Research and Human Retroviruses

Volumn 28, Issue 12, 2012, Pages 1617-1626

  Corró, Guillermo ^a,b   Rocco, Carlos A ^a   De Candia, Cristian ^c   Catano, Gabriel ^d   Turk, Gabriela ^c   Mangano, Andrea ^a,b   Aulicino, Paula C ^a,b   Bologna, Rosa ^a   Sen, Luisa ^a,b  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b Consejo Nacional de Investigaciones Científicas y Tecnológicas ^*  (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MOLECULAR CLONING; PRIORITY JOURNAL;

ADOLESCENT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; DOWN-REGULATION; FEMALE; GENETIC VARIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROVIRUSES; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 84866993309     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0020     Document Type: Article

References (54)

1. Mikhail M, Wang B, and Saksena NK: Mechanisms involved in non-progressive HIV disease. AIDS Rev 2003;5:230-244.
2. Rodés B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito JM, Jimenez V, Wrin T, Bassani S, and Soriano V: Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 2004;18:1109-1116.
3. Anastassopoulou CG and Kostrikis LG: The impact of human allelic variation on HIV disease. Curr HIV Res 2003;1:185-203.
4. den Uyl D, van der Horst-Bruinsma IE, and van Agtmael M: Progression of HIV to AIDS: A protective role for HLA-B57? AIDS Rev 2004;6:89-96.
5. Mangano A, Prada F, Roldán A, Picchio G, Bologna R, and Sen L: Distribution of CCR5 allele in Argentinean children at risk of HIV-1 infection: Its role in vertical transmission. AIDS 1998;12:109-110.
6. Mangano A, Kopka J, Batalla M, Bologna R, and Sen L: Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3¢A in pediatric HIV-1 infection. J Acquir Immune Defic Syndr 2000;23:52-57.
7. Mangano A, Gonzalez E, Dhanda R, Catano G, Bamshad M, Bock A, Duggirala R, Williams K, Mummidi S, Clark RA, Ahuja SS, Dolan MJ, Bologna R, Sen L, and Ahuja SK: Concordance between CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis 2001;183:1574-1585.
8. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'Connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, and Ahuja SK: The influence of CCL3L1 gene-containing segmental duplications in HIV-1/AIDS susceptibility. Science 2005;307:1434-1440.
9. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, and Goulder P: Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 2006;80(7):3617-3623.
10. Carlson JM and Brumme ZL: HIV evolution in response to HLA-restricted CTL selection pressures: A population-based perspective. Microbes Infect 2008;10(5):455-461.
11. Barker E, Mackewicz CE, Reyes-Teran G, Sato A, Stranford SA, Fujimura SH, Christopherson C, Chang SY, and Levy JA: Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 1998;92:3105-3114.
12. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, and Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994;179:115-123.
13. Greenway AG, Holloway G, McPhee DA, Ellis P, Cornall A, and Lidman M: HIV-1 Nef control of cell signalling molecules: Multiple strategies to promote virus replication. J Biosci 2003;28:323-335.
14. Geyer M, Fackler OT, and Peterlin BM: Structure-function relationships in HIV-1 Nef. EMBO Rep 2001;2:580-585.
15. Wildum S, Schindler M, Münch J, and Kirchhoff F: Contribution of Vpu, Env and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 2006;80:8047-8059.
16. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, and Jolicoeur P: Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop severe AIDS-like disease. J Virol 1998;72:121-132.
17. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, and Joli-coeur P: Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998;95:163-175.
18. Kestler HW 3rd, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, and Desrosiers RC: Importance of the nef gene for maintenance of high viral loads and for development of AIDS. Cell 1991;65:651-662.
19. Joseph AM, Kumar M, and Mitra D: Nef: "Necessary and enforcing factor" in HIV infection. Curr HIV Res 2005;3:87-94.
20. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, and Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with non-progressive HIV-1 infection. N Engl J Med 1995;332:228-232.
21. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, and Skowronski J: High frequency of defective nef alleles in a long-term survivor with non progressive HIV-1 infection. J Virol 1996;70:7752-7764.
22. Carl S, Daniels R, Iafrate AJ, Easterbrook P, Greenough TC, Skowronski J, and Kirchhoff F: Partial "repair" of defective NEF genes in a long-term non progressor with HIV-1 infection. J Infect Dis 2000;181:132-140.
23. Churchill MJ, Rhodes DI, Learmont JC, Sullivan JS, Wesse-lingh SL, Cooke IR, Deacon NJ, and Gorry PR: Longitudinal analysis of HIV-1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source. J Virol 2006;80:1047-1052.
24. Salvi R, Garbuglia AR, Di Caro A, Pulciani S, Montella F, and Benedetto A: Grossly defective nef sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 1998;72:3646-3657.
25. Brambilla A, Turchetto L, Gatti A, Bovolenta C, Veglia F, Santagostino E, Gringeri A, Clementi M, Poli G, Bagnarelli P, and Vicenzi E: Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. Virology 1999;259:349-368.
26. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, and Mills J: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-991.
27. Michael NL, Chang G, d'Arcy LA, Tseng CJ, Birx DL, and Sheppard HW: Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J Virol 1995;69:6758-6769.
28. Kirchhoff F, Easterbrook PJ, Douglas N, Troop M, Green-ough TC, Weber J, Carl S, Sullivan JL, and Daniels RS: Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol 1999;73(7):5497-5508.
29. Casartelli N, Di Matteo G, Argentini C, Cancrini C, Bernardi S, Castelli G, Scarlatti G, Plebani A, Rossi P, and Doria M: Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressors children. AIDS 2003;17:1291-1301.
30. Geffin R, Wolf D, Müller R, Hill MD, Stellwag E, Freitag M, Sass G, Scott GB, and Baur AS: Functional and structural defects in HIV-1 nef genes derived from pediatric long-term survivors. AIDS Res Hum Retroviruses 2000;16:1855-1868.
31. Walker PR, Ketunuti M, Choge IA, Meyers T, Gray G, Holmes EC, and Morris L: Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children. AIDS Res Hum Retroviruses 2007;23:204-215.
32. Foster JL and García JV: HIV-1 Nef: At the crossroads. Ret-rovirology 2008;5:84.
33. Gomez Carrillo M, Avila M, Hierholzer J, Pando M, Martinez PL, McCutchan FE, and Carr JK: Mother-to-child transmssion in Argentina: BF recombinants have predominated in infected children since the mid-1980s. AIDS Res Hum Retroviruses 2002;18:477-483.
34. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
35. Kumar S, Tamura K, and Jakobsen IB: MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 2001; 17:1244-1245.
36. Turk G, Gundlach S, Carobene M, Schindler M, Salomon H, and Benaroch P: Single Nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions. AIDS Res Hum Retroviruses 2009;25(3):285-296.
37. Rhodes DI, Ashton L, Solomon A, Carr A, Cooper D, Kaldor J, and Deacon N: Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. J Virol 2000;74:10581-10588.
38. Kondo M, Shima T, Nishizawa M, Sudo K, Iwamuro S, Okabe T, Takebe Y, and Imai M: Identification of attenuated variants of HIV-1 circulating recombinant form 01-AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences. Infect Dis 2005;192(1):56-61.
39. Miura T, Brockman MA, Brumme CJ, Brumme ZL, Carlson JM, Pereyra F, Trocha A, Addo MM, Block BL, Rothchild AC, Baker BM, Flynn T, Schneidewind A, Li B, Wang YE, Heckerman D, Allen TM, and Walker BD: Genetic characterization of human immunodeficiency virus type 1 in elite controllers: Lack of gross genetic defects or common amino acid changes. J Virol 2008;82:8422-8430.
40. Pushker R, Jacqué JM, and Shields DC: Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression. J Virol 2010;84(7):3644-3653.
41. Saloojee H and Violari A: HIV infection in children. BMJ 2001;323:670-674.
42. Scott GB, Hutto C, Makuch R, Mastrucci MT, O'Connor T, Mitchell CD, Trapido EJ, and Parks WP: Survival in children with perinatally acquired immunodeficiency virus (HIV) infection: Experience with 172 children in Miami, Florida. N Engl J Med 1989;321:1791-1796.
43. Duliege A, Messiah A, Blanche S, Tardieu M, Griscelli C, and Spira A: Natural history of human immunodeficiency virus type 1 infection in children: Prognostic value of laboratory tests on the bimodal progression of the disease. Pediatr Infect Dis J 1992;11:630-635.
44. European Collaborative Study: Natural history of vertically acquired human immunodeficiency virus type 1 infection. Pediatrics 1994;94:815-819.
45. Galli L, de Martino M, Tovo PA, Gabiano C, Zappa M, Giaquinto C, Tulisso S, Vierucci A, Guerra M, and Marchisio P: Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995;9:455-461.
46. Ministerio de Salud y Ambiente de la Nación: Bolet'in sobre el HIV/SIDA en la Argentina. Programa Nacional de Lucha contra los Retrovirus del Humano, SIDA y ETS. 2005, Year XI, number 24. Available at http://www.msal.gov. ar/sida/site/datos-epid-boletines.asp.
47. Chakraborty R, Reinis M, Rostron T, Philpott S, Dong T, D'Agostino A, Musoke R, Silva E, Stumpf M, Weiser B, Burger H, and Rowland-Jones SL: nef gene sequence variation among HIV-1-infected African children. HIV Med 2006;7:75-84.
48. Zuo J, Suen J, Wong A, Lewis M, Ayub A, Belzer M, Church J, Yang OO, and Krogstad P: Functional analysis of HIV type 1 Nef gene variants from adolescent and adult survivors of perinatal infection. AIDS Res Hum Retroviruses 2012;28(5):486-492.
49. Casartelli N, Di Matteo G, Potestà M, Rossi P, and Doria M: CD4 and major histocompatibility complex class I down-regulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression. J Virol 2003;77(21):11536-11545.
50. Carl S, Greenough TC, Krumbiegel M, Greenberg M, Skowronski J, Sullivan JL, and Kirchhoff F: Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol 2001;75(8):3657-3665.
51. Brenner M, Münch J, Schindler M, Wildum S, Stolte N, Stahl-Hennig C, Fuchs D, Mätz-Rensing K, Franz M, Heeney J, Ten Haaft P, Swigut T, Hrecka K, Skowronski J, and Kirchhoff F: Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques. J Virol 2006;80:4469-4481.
52. Iafrate AJ, Carl S, Bronson S, Stahl-Hennig C, Swigut T, Skowronski J, and Kirchhoff F: Disrupting surfaces of Nef for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J Virol 2000;74:9836-9844.
53. Huang MB, Jin LL, James CO, Khan M, Powell MD, and Bond VC: Characterization of Nef-CXCR4 interactions important for apoptosis induction. J Virol 2004;78:11084-11096.
54. + T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol 2004;78:3099-3109.